| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. | CHIEF LEGAL OFFICER | Stock Option (Right to Buy) | 450K | Feb 28, 2025 | Direct | ||
| ZOGENIX, INC. | EVP, GC & Secretary | Common Stock | 0 | $26.04 | Mar 7, 2022 | Direct | |
| ZOGENIX, INC. | EVP, GC & Secretary | Restricted Stock Units | 0 | Mar 7, 2022 | Direct | ||
| ZOGENIX, INC. | EVP, GC & Secretary | Stock Option (Right to Buy) | 0 | $26.09 | Mar 7, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | Feb 28, 2025 | 1 | $0 | 4 | Mar 3, 2025 | CHIEF LEGAL OFFICER |
| OLMA | Olema Pharmaceuticals, Inc. | Feb 18, 2025 | 0 | $0 | 3 | Feb 28, 2025 | CHIEF LEGAL OFFICER |
| ZGNX | ZOGENIX, INC. | Mar 7, 2022 | 4 | $0 | 4 | Mar 9, 2022 | EVP, GC & Secretary |